AXACTOR ASA (ACR.OL) Stock Fundamental Analysis

OSL:ACR • NO0010840515

7.34 NOK
-0.16 (-2.13%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

3

Taking everything into account, ACR scores 3 out of 10 in our fundamental rating. ACR was compared to 8 industry peers in the Consumer Finance industry. Both the profitability and financial health of ACR have multiple concerns. ACR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ACR has reported negative net income.
  • ACR had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ACR reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ACR reported negative operating cash flow in multiple years.
ACR.OL Yearly Net Income VS EBIT VS OCF VS FCFACR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • ACR has a Return On Assets of -4.57%. This is in the lower half of the industry: ACR underperforms 75.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -16.24%, ACR is doing worse than 75.00% of the companies in the same industry.
  • The Return On Invested Capital of ACR (1.01%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.57%
ROE -16.24%
ROIC 1.01%
ROA(3y)-0.53%
ROA(5y)-1.09%
ROE(3y)-2.46%
ROE(5y)-4.4%
ROIC(3y)N/A
ROIC(5y)N/A
ACR.OL Yearly ROA, ROE, ROICACR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • ACR has a Operating Margin (9.90%) which is in line with its industry peers.
  • The Gross Margin of ACR (98.12%) is better than 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of ACR has grown nicely.
Industry RankSector Rank
OM 9.9%
PM (TTM) N/A
GM 98.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y5.97%
ACR.OL Yearly Profit, Operating, Gross MarginsACR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACR is destroying value.
  • Compared to 1 year ago, ACR has about the same amount of shares outstanding.
  • The number of shares outstanding for ACR has been increased compared to 5 years ago.
  • The debt/assets ratio for ACR is higher compared to a year ago.
ACR.OL Yearly Shares OutstandingACR.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACR.OL Yearly Total Debt VS Total AssetsACR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • Based on the Altman-Z score of 0.24, we must say that ACR is in the distress zone and has some risk of bankruptcy.
  • ACR has a better Altman-Z score (0.24) than 62.50% of its industry peers.
  • The Debt to FCF ratio of ACR is 4.17, which is a neutral value as it means it would take ACR, 4.17 years of fcf income to pay off all of its debts.
  • ACR has a better Debt to FCF ratio (4.17) than 75.00% of its industry peers.
  • A Debt/Equity ratio of 2.25 is on the high side and indicates that ACR has dependencies on debt financing.
  • ACR's Debt to Equity ratio of 2.25 is on the low side compared to the rest of the industry. ACR is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 4.17
Altman-Z 0.24
ROIC/WACC0.11
WACC8.97%
ACR.OL Yearly LT Debt VS Equity VS FCFACR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • ACR has a Current Ratio of 0.99. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of ACR (0.99) is better than 62.50% of its industry peers.
  • ACR has a Quick Ratio of 0.99. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ACR has a Quick ratio of 0.99. This is in the better half of the industry: ACR outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
ACR.OL Yearly Current Assets VS Current LiabilitesACR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

  • The earnings per share for ACR have decreased strongly by -379.79% in the last year.
  • ACR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.15%.
  • The Revenue for ACR have been decreasing by -14.81% on average. This is quite bad
EPS 1Y (TTM)-379.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.07%
Revenue 1Y (TTM)-50.15%
Revenue growth 3Y-6.85%
Revenue growth 5Y-14.81%
Sales Q2Q%259.33%

3.2 Future

  • ACR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.40% yearly.
  • The Revenue is expected to grow by 17.59% on average over the next years. This is quite good.
EPS Next Y144.8%
EPS Next 2Y60.9%
EPS Next 3Y36.4%
EPS Next 5YN/A
Revenue Next Year51.68%
Revenue Next 2Y26.02%
Revenue Next 3Y17.59%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ACR.OL Yearly Revenue VS EstimatesACR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ACR.OL Yearly EPS VS EstimatesACR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ACR. In the last year negative earnings were reported.
  • ACR is valuated cheaply with a Price/Forward Earnings ratio of 4.23.
  • Based on the Price/Forward Earnings ratio, ACR is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. ACR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.23
ACR.OL Price Earnings VS Forward Price EarningsACR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • ACR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ACR is cheaper than 62.50% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACR indicates a rather cheap valuation: ACR is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.02
EV/EBITDA 38.37
ACR.OL Per share dataACR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ACR's earnings are expected to grow with 36.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.9%
EPS Next 3Y36.4%

0

5. Dividend

5.1 Amount

  • No dividends for ACR!.
Industry RankSector Rank
Dividend Yield 0%

AXACTOR ASA

OSL:ACR (2/27/2026, 7:00:00 PM)

7.34

-0.16 (-2.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners8.78%
Inst Owner ChangeN/A
Ins Owners3.29%
Ins Owner ChangeN/A
Market Cap2.22B
Revenue(TTM)127.94M
Net Income(TTM)-58.22M
Analysts75
Price Target9.49 (29.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.44%
Min EPS beat(2)-24.09%
Max EPS beat(2)15.21%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.81%
Min Revenue beat(2)-13.86%
Max Revenue beat(2)0.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.06%
PT rev (3m)-1.06%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)8.57%
EPS NY rev (1m)0%
EPS NY rev (3m)1.67%
Revenue NQ rev (1m)25.69%
Revenue NQ rev (3m)27.66%
Revenue NY rev (1m)3.98%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.23
P/S 1.34
P/FCF 1.02
P/OCF 1
P/B 0.55
P/tB 0.68
EV/EBITDA 38.37
EPS(TTM)-2.95
EYN/A
EPS(NY)1.74
Fwd EY23.65%
FCF(TTM)7.22
FCFY98.32%
OCF(TTM)7.34
OCFY99.98%
SpS5.48
BVpS13.3
TBVpS10.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -16.24%
ROCE 1.25%
ROIC 1.01%
ROICexc 1.05%
ROICexgc 1.12%
OM 9.9%
PM (TTM) N/A
GM 98.12%
FCFM 131.59%
ROA(3y)-0.53%
ROA(5y)-1.09%
ROE(3y)-2.46%
ROE(5y)-4.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y5.97%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 4.17
Debt/EBITDA 32.14
Cap/Depr 31.37%
Cap/Sales 2.23%
Interest Coverage 0.2
Cash Conversion 787.27%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 0.24
F-Score3
WACC8.97%
ROIC/WACC0.11
Cap/Depr(3y)41.35%
Cap/Depr(5y)45.86%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-379.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.07%
EPS Next Y144.8%
EPS Next 2Y60.9%
EPS Next 3Y36.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.15%
Revenue growth 3Y-6.85%
Revenue growth 5Y-14.81%
Sales Q2Q%259.33%
Revenue Next Year51.68%
Revenue Next 2Y26.02%
Revenue Next 3Y17.59%
Revenue Next 5YN/A
EBIT growth 1Y-86.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.31%
EBIT Next 3Y30.32%
EBIT Next 5Y17.1%
FCF growth 1Y1123.46%
FCF growth 3Y9.09%
FCF growth 5YN/A
OCF growth 1Y901.89%
OCF growth 3Y8.3%
OCF growth 5YN/A

AXACTOR ASA / ACR.OL FAQ

What is the ChartMill fundamental rating of AXACTOR ASA (ACR.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACR.OL.


Can you provide the valuation status for AXACTOR ASA?

ChartMill assigns a valuation rating of 6 / 10 to AXACTOR ASA (ACR.OL). This can be considered as Fairly Valued.


What is the profitability of ACR stock?

AXACTOR ASA (ACR.OL) has a profitability rating of 2 / 10.


Is the dividend of AXACTOR ASA sustainable?

The dividend rating of AXACTOR ASA (ACR.OL) is 0 / 10 and the dividend payout ratio is 0%.